No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Samsung Bioepis Releases Fourth Biosimilar Market Report: US Adalimumab Biosimilar Uptake Only 2%
On 17 January 2024 Samsung Bioepis released its fourth US Biosimilar Market Report. The quarterly report details recent prices of US-launched biosimilars, and market share and price trends. The report covers the US-approved biosimilars on 14 INNs, of which 45 have...